Oasis Pharma
プレミアムジェネリック医薬品と特殊な臨床機器
当社は安全な医薬品と病院用機器を医療チャネル全体に流通させています。当社の上位ストレージ設定では、高度な環境追跡自動化が採用されています。スピードを優先し、バッチ記録を完了します。
- Type
- distributor (our classification of the record, not a statement by the company)
- Role
- Distributor
- Location
- Dubai, United Arab Emirates
- Founded
- 2001
- Website
- oasispharma.ae
- Categories
- 医療およびヘルスケア用品, 産業オートメーションとロボティクス
- Markets
- アラブ首長国連邦, オマーン
What is established and what is not
No facet of this company has been investigated yet. The facts below are collected records, not an assessment: nothing here confirms manufacturing, ownership or trading status beyond what each record literally says.
Verified facts
- debarment-clear (green), checked 2026-08-12 - screened by name only: no legal entity is established for this record, so this is not a clearance OpenSanctions
- sanctions-clear (green), checked 2026-08-12 - screened by name only: no legal entity is established for this record, so this is not a clearance OpenSanctions
Import rules for these goods
- Medical devices sold in the EU must carry CE marking under the Medical Device Regulation (EU) 2017/745, with a conformity assessment matched to the device risk class. European Commission (MDR)
- For the US market, the maker must have an FDA device establishment registration and product listing; most instruments also need 510(k) premarket clearance. US FDA (devices)
- Machinery sold in the EU needs CE marking with a declaration of conformity under the EU machinery rules. European Commission